Association between TNF-α promoter −308 A/G polymorphism and Alzheimer’s disease: a meta-analysis

Neurological Sciences

Volumn 36, Issue 6, 2015, Pages 825-832

  Lee, Young Ho ^a   Choi, Sung Jae ^a   Ji, Jong Dae ^a   Song, Gwan Gyu ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Meta analysis; Polymorphism; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

AFRICAN AMERICAN; ALLELE; ALZHEIMER DISEASE; EAST ASIAN; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MIDDLE EAST; PROMOTER REGION; PUBLISHING; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; CAUCASIAN; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PROCEDURES;

ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930382279     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-015-2102-8     Document Type: Review

References (35)

1. Boada M, Antunez C, Lopez-Arrieta J, Caruz A, Moreno-Rey C, Ramirez-Lorca R et al (2012) Estrogen receptor alpha gene variants are associated with Alzheimer’s disease. Neurobiol Aging 33(1):198.e15–198.e24
2. Medway C, Morgan K (2014) Review: the genetics of Alzheimer’s disease; putting flesh on the bones. Neuropathol Appl Neurobiol 40(2):97–105
3. Vasto S, Candore G, Listi F, Balistreri CR, Colonna-Romano G, Malavolta M et al (2008) Inflammation, genes and zinc in Alzheimer’s disease. Brain Res Rev 58(1):96–105
4. Liu L, Chan C (2014) The role of inflammasome in Alzheimer’s disease. Ageing Res Rev 15:6–15
5. McGeer PL, McGeer EG (2001) Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 58(11):1790–1792
6. Perry RT, Collins JS, Wiener H, Acton R, Go RC (2001) The role of TNF and its receptors in Alzheimer’s disease. Neurobiol Aging 22(6):873–883
7. Himmerich H, Berthold-Losleben M, Pollmacher T (2009) The relevance of the TNF-alpha system in psychiatric disorders. Fortschr Neurol Psychiatr 77(6):334–345
8. Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B (1999) TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J 13(1):63–68
9. Allen RD (1999) Polymorphism of the human TNF-alpha promoter—random variation or functional diversity? Mol Immunol 36(15–16):1017–1027
10. D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39(2):150–154
11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94(7):3195–3199
12. Ardebili SM, Yeghaneh T, Gharesouran J, Rezazadeh M, Farhoudi M, Ayromlou H et al (2011) Genetic association of TNF-alpha −308 G/A and -863 C/A polymorphisms with late onset Alzheimer’s disease in Azeri Turk population of Iran. J Res Med Sci 16(8):1006–1013
13. Shawkatova I, Javor J, Parnicka Z, Vrazda L, Novak M, Buc M (2010) No association between cytokine gene polymorphism and risk of Alzheimer’s disease in Slovaks. Acta Neurobiol Exp (Wars) 70(3):303–307
14. Manoochehri M, Kamali K, Rahgozar M, Ohadi M, Farrokhi H, Khorshid HR (2009) Lack of association between tumor necrosis factor-alpha −308 G/A polymorphism and risk of developing late-onset Alzheimer’s disease in an Iranian Population. Avicenna J Med Biotechnol 1(3):193–197
15. Yang L, Lu R, Jiang L, Liu Z, Peng Y (2009) Expression and genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G −308A polymorphism in sporadic Alzheimer’s disease in a Southern China population. Brain Res 1247:178–181
16. Tedde A, Putignano AL, Nacmias B, Bagnoli S, Cellini E, Sorbi S (2008) Lack of association between TNF-alpha polymorphisms and Alzheimer’s disease in an Italian cohort. Neurosci Lett 446(2–3):139–142
17. Wang B, Zhou S, Yang Z, Xie YC, Wang J, Zhang P et al (2008) Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G −308A and Saitohin Q7R polymorphisms with Alzheimer’s disease. J Neurol Sci 270(1–2):148–151
18. Ramos EM, Lin MT, Larson EB, Maezawa I, Tseng LH, Edwards KL et al (2006) Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Arch Neurol 63(8):1165–1169
19. Lio D, Annoni G, Licastro F, Crivello A, Forte GI, Scola L et al (2006) Tumor necrosis factor-alpha −308A/G polymorphism is associated with age at onset of Alzheimer’s disease. Mech Ageing Dev 127(6):567–571
20. Laws SM, Perneczky R, Wagenpfeil S, Muller U, Forstl H, Martins RN et al (2005) TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels. Hum Mutat 26(1):29–35
21. Zhang P, Yang Z, Wan CL, Zheng WD, Zhang CF, Li S et al (2004) Neither the tumor necrosis factor alpha −308 A/G polymorphism nor the alpha2-macroglobulin polymorphism was associated with late-onset Alzheimer’s disease in the Chinese population. Yi Chuan Xue Bao 31(1):1–6
22. Alvarez V, Mata IF, Gonzalez P, Lahoz CH, Martinez C, Pena J et al (2002) Association between the TNFalpha −308 A/G polymorphism and the onset-age of Alzheimer disease. Am J Med Genet 114(5):574–577
23. Perry RT, Collins JS, Harrell LE, Acton RT, Go RC (2001) Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 105(4):332–342
24. Tarkowski E, Liljeroth AM, Nilsson A, Ricksten A, Davidsson P, Minthon L et al (2000) TNF gene polymorphism and its relation to intracerebral production of TNFalpha and TNFbeta in AD. Neurology 54(11):2077–2081
25. Flex A, Giovannini S, Biscetti F, Liperoti R, Spalletta G, Straface G et al (2014) Effect of proinflammatory gene polymorphisms on the risk of Alzheimer’s disease. Neurodegener Dis 13(4):230–236
26. Gnjec A, D’Costa KJ, Laws SM, Hedley R, Balakrishnan K, Taddei K et al (2008) Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer’s disease. J Neuroinflammation 5:36
27. Sarajarvi T, Helisalmi S, Antikainen L, Makinen P, Koivisto AM, Herukka SK et al (2010) An association study of 21 potential Alzheimer’s disease risk genes in a Finnish population. J Alzheimers Dis 21(3):763–767
28. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG (2010) Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep 37(1):227–234
29. Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27(9):827–833
30. Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 38(6):3643–3651
31. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558
32. Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315(7121):1533–1537
33. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188
34. Lee YH, Ji JD, Song GG (2007) Tumor necrosis factor-alpha promoter −308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 34(1):43–49
35. Di Bona D, Candore G, Franceschi C, Licastro F, Colonna-Romano G, Camma C et al (2009) Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer’s disease. Brain Res Rev 61(2):60–68